Results 61 to 70 of about 60,113 (237)

Myocardial Feature Tracking Reduces Observer-Dependence in Low-Dose Dobutamine Stress Cardiovascular Magnetic Resonance

PLoS ONE, 2015
Objectives To determine whether quantitative wall motion assessment by CMR myocardial feature tracking (CMR-FT) would reduce the impact of observer experience as compared to visual analysis in patients with ischemic cardiomyopathy (ICM).
A. Schuster, Matthias Paul, N. Bettencourt, Shazia T. Hussain, G. Morton, S. Kutty, B. Bigalke, A. Chiribiri, D. Perera, E. Nagel, P. Beerbaum   +10 more
semanticscholar   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Peripartum cardiomyopathy – An insight

The Indian Anaesthetists' Forum, 2020
Peripartum cardiomyopathy (PPCM) is a potentially life-threatening disease. However, timely intervention and early detection can save lives. It presents in peripartum period as left ventricular dysfunction and heart failure.
Namita Saraswat, Pooja Virmani, Aanchal Kakkar, Akhilesh Gupta, Mohandeep Kaur   +4 more
doaj   +1 more source

The association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: A preliminary study [PDF]

, 2012
Introduction: The product of heart rate and systolic blood pressure, termed as rate-pressure product (RPP), is a very reliable indicator of myocardial oxygen demand and is widely used clinically.
Abbaszadeh, M., Amini, A., Ansari, M., Assadi, M., Barekat, M., Jallalat, S., Javadi, H., Mogharrabi, M., Nabipour, I., Pourbehi, M., Rayzan, M., Semnani, S.   +11 more
core   +1 more source

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function

Indian Heart Journal, 2021
To assess the clinical outcomes of levosimendan and dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function in Indian scenario.
Basil John, Pharm D, Mariya Babu, Pharm D, Sandramol shaji, Pharm D, Suja Abraham, Jabir Abdullakutty   +4 more
doaj   +1 more source

What every ICU clinician needs to know about the cardiovascular effects caused by abdominal hypertension [PDF]

, 2015
The effects of increased intra-abdominal pressure (IAP) on cardiovascular function are well recognized and include a combined negative effect on preload, afterload and contractility.
De Keulenaer, Bart L, De Waele, Jan, Malbrain, Manu LNG   +2 more
core   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease [PDF]

, 1994
purpose: To compare the relative value of clinical variables with dobutamine-atropine stress echocardiography to predict cardiac events during long-term follow-up.
Arnese, M. (Mariarosaria), Boersma, H. (Eric), Borst, F. (Filip), Cornel, J.H. (Jan), Elhendy, A. (Abdou), Fioretti, P.M. (Paolo), Poldermans, D. (Don), Roelandt, J.R.T.C. (Jos), Vermeulen, E.G.J. (Erik)   +8 more
core   +1 more source

Dobutamine-Induced Myoclonus in a Patient With Advanced Heart Failure and Chronic Kidney Disease

JACC: Case Reports
Dobutamine is a positive inotropic agent often used in treatment of cardiogenic shock. Although there are well-documented adverse effects, dobutamine-induced myoclonus is a rarely reported phenomenon.
Alexander Y. Lee, MD, Shiva Barforoshi, MD, Alvin Singh, MD, Ritesh Shrestha, MD, James Ha, MD, Michelle Kittleson, MD, PhD   +5 more
doaj   +1 more source

Coronary flow reserve during dobutamine stress in Takotsubo stress cardiomyopathy

BMJ Open, 2015
Objectives Takotsubo stress cardiomyopathy (TSC) is an increasingly recognised and diagnosed disease, although the underlying pathophysiology is still unknown. Our aim was to investigate the effect of the catecholamine dobutamine on coronary flow reserve
O. Collste, P. Tornvall, Mahbubul Alam, M. Frick   +3 more
semanticscholar   +1 more source